Business Context and Reporting Period
This Form 8-K was filed by Pavmed Inc. on February 12, 2018. The company is incorporated in Delaware and is designated as an emerging growth company. The report addresses corporate governance changes rather than financial performance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statements.
Material Changes
On February 12, 2018, two directors, Ira S. Greenspan and Joshua R. Lamstein, resigned from the Board of Directors effective immediately. The company stated that neither resignation was due to any disagreement with the Company or its management regarding operations, policies, or practices. As a result of these departures, the Board now consists of a majority of independent directors, satisfying Nasdaq listing standards.
Guidance, Outlook, and Risks
The filing contains no management commentary on future guidance, outlook, or specific risks. The only contingency noted is the immediate reduction in board membership, which was resolved by achieving a majority of independent directors.
Investor Verification Checklist
- Verify the current composition of the Board of Directors to confirm the majority independent status.
- Confirm that no undisclosed disagreements exist between the departing directors and management.
- Review subsequent filings for the appointment of new directors to fill the vacancies.